Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Cofer

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of Surgical Oncology|March 1, 1996
Infantile fibrosarcoma: complete excision is the appropriate treatmentB R Cofer, P J Vescio, E S Wiener
Transplantation Proceedings|December 1, 1991
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survivalC B Davies, B R Cofer, J W Alexander
Transplantation|March 27, 1995
Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverageJ I Tchervenkov, B R Cofer, C Davies, et al.
The Journal of Trauma|January 1, 1991
Penetrating injury of a duplicated ureter: case reportB R Cofer, P N Kaufman, M S Nussbaum, et al.
Journal of Pediatric Surgery|May 1, 1993
Extracorporeal membrane oxygenation in the management of cardiac failure secondary to myocarditisB R Cofer, B W Warner, A Stallion, et al.
Transplantation|November 1, 1992
The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survivalB R Cofer, C B Davies, J W Alexander, et al.
Transplantation Proceedings|February 1, 1991
Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative periodB R Cofer, J I Tchervenkov, J W Alexander, et al.
Transplantation Proceedings|February 1, 1991
Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporineM E Brunson, J I Tchervenkov, J W Alexander, et al.
Perfusion|January 1, 1994
The significant relationship between platelet count and haemorrhagic complications on ECMOA Stallion, B R Cofer, J A Rafferty, et al.
Annals of Surgery|June 1, 1992
Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplantC B Davies, J W Alexander, B R Cofer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of Surgical Oncology|March 1, 1996
Infantile fibrosarcoma: complete excision is the appropriate treatmentB R Cofer, P J Vescio, E S Wiener
Transplantation Proceedings|December 1, 1991
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survivalC B Davies, B R Cofer, J W Alexander
Transplantation|March 27, 1995
Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverageJ I Tchervenkov, B R Cofer, C Davies, et al.
The Journal of Trauma|January 1, 1991
Penetrating injury of a duplicated ureter: case reportB R Cofer, P N Kaufman, M S Nussbaum, et al.
Journal of Pediatric Surgery|May 1, 1993
Extracorporeal membrane oxygenation in the management of cardiac failure secondary to myocarditisB R Cofer, B W Warner, A Stallion, et al.
Transplantation|November 1, 1992
The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survivalB R Cofer, C B Davies, J W Alexander, et al.
Transplantation Proceedings|February 1, 1991
Donor-specific transfusion and cyclosporine prolong allograft survival when given in the peroperative periodB R Cofer, J I Tchervenkov, J W Alexander, et al.
Transplantation Proceedings|February 1, 1991
Partial T-cell depletion with monoclonal antibody improves the enhancing effect of donor-specific transfusion plus cyclosporineM E Brunson, J I Tchervenkov, J W Alexander, et al.
Perfusion|January 1, 1994
The significant relationship between platelet count and haemorrhagic complications on ECMOA Stallion, B R Cofer, J A Rafferty, et al.
Annals of Surgery|June 1, 1992
Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplantC B Davies, J W Alexander, B R Cofer, et al.
Pageof 2